Stay updated on CPX-351 and Ivosidenib in IDH1 AML Clinical Trial

Sign up to get notified when there's something new on the CPX-351 and Ivosidenib in IDH1 AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CPX-351 and Ivosidenib in IDH1 AML Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The page revision indicator was updated from v3.5.2 to v3.5.3, reflecting a change to the site’s display/versioning rather than the underlying clinical trial record content.
    Difference
    0.1%
    Check dated 2026-04-24T16:45:55.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 to the history. Deleted Revision: v3.5.0 from the history.
    Difference
    0.1%
    Check dated 2026-04-17T13:47:40.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    A new version entry was added on 2025-11-20 showing updated study status and recruitment details. The history now reflects the latest changes to the trial record.
    Difference
    0.1%
    Check dated 2026-04-03T05:33:42.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Revision history now includes the addition of v3.5.0 and the deletion of v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T22:23:15.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added to the history and Revision: v3.4.2 was removed. This update reflects administrative changes to the record history.
    Difference
    0.1%
    Check dated 2026-03-12T20:23:39.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the history, and removed the site-wide funding/operating-status notice along with the prior Revision: v3.4.1 entry. These changes relate to site-wide notices and version labeling rather than the core study content.
    Difference
    0.7%
    Check dated 2026-02-11T21:15:48.000Z thumbnail image

Stay in the know with updates to CPX-351 and Ivosidenib in IDH1 AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CPX-351 and Ivosidenib in IDH1 AML Clinical Trial page.